| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00101-017-0329-X |
| P698 | PubMed publication ID | 28677016 |
| P2093 | author name string | L Martin | |
| C Thiemermann | |||
| T Schürholz | |||
| M Derwall | |||
| P2860 | cites work | Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model | Q22000596 |
| Comparison of Dopamine and Norepinephrine in the Treatment of Shock | Q22250880 | ||
| Bench-to-bedside review: sepsis is a disease of the microcirculation | Q24800640 | ||
| CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction. | Q54535260 | ||
| Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart. | Q54545982 | ||
| Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial | Q57778873 | ||
| In Vivo Expression of Proinflammatory Mediators in the Adult Heart after Endotoxin Administration: The Role of Toll‐Like Receptor–4 | Q59192150 | ||
| Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9 | Q59200919 | ||
| Sepsis and Endothelial Permeability | Q59227670 | ||
| Inhibition of Mitochondrial Permeability Transition Prevents Sepsis-Induced Myocardial Dysfunction and Mortality | Q59607578 | ||
| Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: Comparison with dobutamine and milrinone | Q61842194 | ||
| Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans | Q68692688 | ||
| The coronary circulation in human septic shock | Q70014120 | ||
| Myocardial adrenergic responsiveness after lethal and nonlethal doses of endotoxin | Q70164267 | ||
| Initial externalization followed by internalization of beta-adrenergic receptors in rat heart during sepsis | Q71435284 | ||
| Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock | Q71683096 | ||
| Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4 | Q75197360 | ||
| Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis | Q79906000 | ||
| Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart | Q81072723 | ||
| High mobility group box 1 induces a negative inotropic effect on the left ventricle in an isolated rat heart model of septic shock: a pilot study | Q81336575 | ||
| In vivo Toll-like receptor 4 antagonism restores cardiac function during endotoxemia | Q82532647 | ||
| Treatment of myocardial dysfunction in sepsis: the Toll-like receptor antagonist approach | Q82532654 | ||
| Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia | Q83154420 | ||
| [Is there any indication for perioperative use of the pulmonary artery catheter?] | Q83610683 | ||
| Heparin, heparan sulfate and heparanase in inflammatory reactions | Q84845401 | ||
| Effects and mechanism analysis of combined infusion by levosimendan and vasopressin on acute lung injury in rats septic shock | Q87363331 | ||
| Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. | Q50520671 | ||
| Pathophysiologic responses of the subhuman primate in experimental septic shock | Q52476552 | ||
| Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. | Q53541654 | ||
| Sepsis and burn complicated by sepsis alter cardiac transporter expression. | Q53585501 | ||
| Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. | Q54180703 | ||
| Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? | Q54238540 | ||
| ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation. | Q54290446 | ||
| Effects of coronary hypotension and endotoxin on myocardial performance. | Q54426326 | ||
| Sepsis-induced myocardial dysfunction: pathophysiology and management | Q26751572 | ||
| Mitochondrial Mechanisms in Septic Cardiomyopathy | Q26801508 | ||
| Ventriculo-arterial decoupling in acutely altered hemodynamic states | Q26851662 | ||
| Vasoactive agents for the treatment of sepsis | Q28068818 | ||
| The Endothelial Glycocalyx: New Diagnostic and Therapeutic Approaches in Sepsis | Q28072373 | ||
| Bacterial flagellin triggers cardiac innate immune responses and acute contractile dysfunction | Q28573976 | ||
| The immunopathogenesis of sepsis | Q29622909 | ||
| Severity of cardiac impairment in the early stage of community-acquired sepsis determines worse prognosis | Q30317801 | ||
| Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications | Q30318473 | ||
| Speckle tracking echocardiography in patients with septic shock: a case control study (SPECKSS). | Q30383657 | ||
| Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial | Q30726774 | ||
| Myocardial dysfunction in sepsis: a large, unsolved puzzle | Q33353302 | ||
| New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography | Q34467386 | ||
| Role of endothelial heparanase in delayed-type hypersensitivity | Q34557376 | ||
| A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance | Q34560402 | ||
| Dysregulation of intracellular calcium transporters in animal models of sepsis-induced cardiomyopathy | Q34725636 | ||
| Vasopressin versus norepinephrine infusion in patients with septic shock. | Q34756330 | ||
| Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model | Q34761833 | ||
| Myocardial dysfunction in the patient with sepsis | Q34925777 | ||
| Role of extracellular histones in the cardiomyopathy of sepsis. | Q35555107 | ||
| Silencing of uncoupling protein 2 by small interfering RNA aggravates mitochondrial dysfunction in cardiomyocytes under septic conditions | Q35609951 | ||
| Peptide 19-2.5 inhibits heparan sulfate-triggered inflammation in murine cardiomyocytes stimulated with human sepsis serum | Q35646306 | ||
| To beta block or not to beta block; that is the question | Q36088227 | ||
| An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction | Q36227873 | ||
| Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock | Q36356245 | ||
| Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis | Q36825545 | ||
| Toll-like receptor 9 promotes cardiac inflammation and heart failure during polymicrobial sepsis | Q37019795 | ||
| The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. | Q37045970 | ||
| Protein phosphatase 2A contributes to the cardiac dysfunction induced by endotoxemia. | Q37120814 | ||
| Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study | Q37360357 | ||
| Bench-to-bedside review: Beta-adrenergic modulation in sepsis. | Q37623067 | ||
| Complications associated with pulmonary artery catheters: a comprehensive clinical review | Q37706486 | ||
| Proteoglycans in health and disease: the multiple roles of syndecan shedding | Q37788814 | ||
| Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility | Q37815210 | ||
| Lipopolysaccharide and sepsis-associated myocardial dysfunction | Q37850260 | ||
| Role of toll-like receptors in cardiovascular diseases | Q37854080 | ||
| Management of myocardial dysfunction in severe sepsis. | Q37867058 | ||
| Characterization of cardiac dysfunction in sepsis: an ongoing challenge | Q38172334 | ||
| Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment | Q38209176 | ||
| Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial | Q38316900 | ||
| Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial | Q38443276 | ||
| Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials | Q38533057 | ||
| Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis. | Q39029084 | ||
| Cardiac fibroblasts: contributory role in septic cardiac dysfunction | Q39200106 | ||
| Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. | Q40367577 | ||
| Detection of Myocardial Dysfunction in Septic Shock: A Speckle-Tracking Echocardiography Study. | Q40511368 | ||
| Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis | Q40657906 | ||
| Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. | Q40733888 | ||
| Impact of Dobutamine in Patients With Septic Shock: A Meta-Regression Analysis | Q40748583 | ||
| Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock | Q40908825 | ||
| Soluble Heparan Sulfate in Serum of Septic Shock Patients Induces Mitochondrial Dysfunction in Murine Cardiomyocytes | Q40925027 | ||
| Circulating Histones Are Major Mediators of Cardiac Injury in Patients With Sepsis. | Q41134828 | ||
| Continuous cardiac output measurement by un-calibrated pulse wave analysis and pulmonary artery catheter in patients with septic shock. | Q41343987 | ||
| Myocardial Dysfunction in Severe Sepsis and Septic Shock: No Correlation With Inflammatory Cytokines in Real-life Clinical Setting | Q41543244 | ||
| The Role of Uncoupling Protein 2 During Myocardial Dysfunction in a Canine Model of Endotoxin Shock | Q41590175 | ||
| Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum | Q41903981 | ||
| Evaluation of left ventricular systolic function revisited in septic shock. | Q42176944 | ||
| G protein and adenylate cyclase complex-mediated signal transduction in the rat heart during sepsis | Q42442342 | ||
| Intraaortic balloon support for myocardial infarction with cardiogenic shock | Q42664790 | ||
| Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome | Q42871311 | ||
| Efficacy and safety of dopamine versus norepinephrine in the management of septic shock | Q43256319 | ||
| Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial | Q43412778 | ||
| Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis | Q43707142 | ||
| Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study | Q43757721 | ||
| Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats | Q43995613 | ||
| Association between mitochondrial dysfunction and severity and outcome of septic shock | Q44074137 | ||
| IL-1beta and IL-6 act synergistically with TNF-alpha to alter cardiac contractile function after burn trauma | Q44188428 | ||
| Postlipopolysaccharide oxidative damage of mitochondrial DNA. | Q44248025 | ||
| Profound but reversible myocardial depression in patients with septic shock | Q44250178 | ||
| Specific inhibition of mitochondrial oxidative stress suppresses inflammation and improves cardiac function in a rat pneumonia-related sepsis model | Q44290150 | ||
| Protective role of PARK2/Parkin in sepsis-induced cardiac contractile and mitochondrial dysfunction | Q45793639 | ||
| The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine | Q46515116 | ||
| Mechanisms of cardiac depression caused by lipoteichoic acids from Staphylococcus aureus in isolated rat hearts | Q46618537 | ||
| Toll-like receptor 4, nitric oxide, and myocardial depression in endotoxemia | Q46862129 | ||
| High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) Ca(2+) leak through TLR4-ROS signaling in cardiomyocytes | Q46878398 | ||
| The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects | Q46902596 | ||
| Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery | Q47877301 | ||
| Use of a Short-Acting β1 Blocker During Endotoxemia May Reduce Cerebral Tissue Oxygenation if Hemodynamics are Depressed by a Decrease in Heart Rate | Q47885980 | ||
| Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases | Q47891975 | ||
| Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis | Q47911806 | ||
| Clinical management of the cardiovascular failure in sepsis | Q48496620 | ||
| Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F]fluoromisonidazole | Q48642254 | ||
| Competitive and noncompetitive inhibition of myocardial cytochrome C oxidase in sepsis | Q48917473 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | German | Q188 |
| P921 | main subject | sepsis | Q183134 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 479-490 | |
| P577 | publication date | 2017-07-04 | |
| P1433 | published in | Anaesthesist | Q1192168 |
| P1476 | title | Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy | |
| P478 | volume | 66 |
| Q48124080 | Ablation of the Right Cardiac Vagus Nerve Reduces Acetylcholine Content without Changing the Inflammatory Response during Endotoxemia. |
| Q110566803 | COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation |
| Q91741502 | Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials |
| Q52608545 | Heparan Sulfate Induces Necroptosis in Murine Cardiomyocytes: A Medical-In silico Approach Combining In vitro Experiments and Machine Learning. |
| Q64947650 | Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application. |
| Q64235524 | Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes |
| Q88412505 | [Sharpen the classical view of septic cardiomyopathy] |
Search more.